ETF Evaluator:
Langar Global HealthTech ETF ()
Follow This ETF
(as of Aug 26)
Best Performing in Health Over the Last Year
| 129.4% | Virtus LifeSci Biotech Clinical Trls ETF (BBC) |
| 94.1% | ALPS Medical Breakthroughs ETF (SBIO) |
| 88.4% | F/m Emerald Life Sciences Innovation ETF (LFSC) |
| 72.5% | State Street® SPDR® S&P® Biotech ETF (XBI) |
| 65.8% | State Street® SPDR® S&P® PhrmctlsETF (XPH) |
Risk
Index
Risk
Index
ETF Details
Langar Global HealthTech ETF Overview
Langar Global HealthTech ETF (LGHT) is an actively managed Sector Equity Health exchange-traded fund (ETF). Langar Funds launched the ETF in 2024.
The investment seeks long-term growth of capital.
Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.
About Langar Global HealthTech ETF (LGHT)
There are 1 members of the management team with an average tenure of 2.55 years: Dhruv Vig (2024). Management tenure is more important for actively managed ETFs than passive index ETFs.
The ETF has 2 primary benchmarks: S&P 500 (TR) (1970) index with a weighting of 100% and S&P 500 Sec/Health Care TR USD index with a weighting of 100%. Langar Global HealthTech ETF has 32 securities in its portfolio. The top 10 holdings constitute 71.6% of the ETF’s assets. The ETF meets the SEC requirement of being classified as a nondiversified fund. The ETF is not considered to have an ESG focus with its investment selection and management.
Langar Global HealthTech ETF is part of the Equity global asset class and is within the Sector Equity ETF group. Langar Global HealthTech ETF has 15.3% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 82.9% There is 15.3% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). Langar Global HealthTech ETF has 1.8% of the portfolio in cash.
Assets Under Management
The fund has $1 million in total assets, which is below the $1 billion average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
LGHT Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The Langar Global HealthTech ETF expense ratio is high compared to funds in the Health category. Langar Global HealthTech ETF has an expense ratio of 0.85%, which is 64% higher than its category average, making the fund expense ratio grade a F. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. Langar Global HealthTech ETF has a portfolio turnover rate of 51%, which indicates that it holds its assets around / 0.0 years. By way of comparison, the average portfolio turnover is 45% for the Health category.
Recently, in the month of July 2026, Langar Global HealthTech ETF returned 1.4%, which earned it a grade of B, as the Health category had an average return of -0.1%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all ETFs in that category.
Langar Global HealthTech ETF has a trailing yield of 0.00%, which is below the 1.10% category average.
The fund normally distributes its income annually and its capital gains annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
Langar Global HealthTech ETF Grades
Year to date, the ETF has returned -13.4%, 23.2 percentage points worse than the category, which translates into a grade of F. The fund has returned -14.3% over the past year (grade of F).
For more ETF grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about Langar Global HealthTech ETF, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
LGHT Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| LGHT Return (NAV) | 1.4% | 4.9% | -14.3% | na | na | na |
| LGHT Return (Price) | 1.4% | 5.1% | -14.3% | na | na | na |
| NAV +/- Price Return | -0.083% | -0.221% | 0.009% | na | na | na |
| Health Avg | -0.1% | 11.2% | 36.9% | 9.9% | 1.6% | 8.7% |
| LGHT Grade (NAV) | B | F | F | na | na | na |
| +/- Category (NAV) | 1.4% | -6.4% | -51.2% | na | na | na |
| LGHT Tax-Cost Ratio | na | na | 0.0% | na | na | na |
LGHT Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| LGHT Return (NAV) | -13.4% | -1.5% | na | na | na | na | na | na | na | na | na |
| LGHT Return (Price) | -14.0% | -0.9% | na | na | na | na | na | na | na | na | na |
| NAV +/- Price Ret | 0.046% | -0.421% | na | na | na | na | na | na | na | na | na |
| Health Avg | 9.7% | 21.8% | 0.1% | 2.2% | -16.3% | 4.3% | 30.5% | 25.4% | -1.5% | 26.5% | -10.2% |
| LGHT Grade (NAV) | F | F | na | na | na | na | na | na | na | na | na |
| +/- Category | -23.2% | -23.3% | na | na | na | na | na | na | na | na | na |
| Risk Measures | |
| Beta: | na |
| R-Squared: | na |
| Standard Deviation: | na |
| Category Risk Index: | na |
| Category Risk Rating: | |
| Total Risk Index: | na |
| Total Risk Rating: | |
| Portfolio Characteristics | |
| Yield: | 0.0% |
| Total Assets: | $ 2 Mil |
| Share Class Assets: | $ 2 Mil |
| Turnover: | 51.9% |
| Expense Ratio: | 0.85% |
| Index Fund: | No |
| Index Tracked: | S&P 500 (TR) (1970) |
| Index Weighting: | 100% |
| Leveraged: | No |
| Socially Responsible Fund: | No |
| Capital Gains Distribution Frequency: | Annually |
| Income Distribution Frequency: | Annually |
Management Team
| Number of Managers: 1 | |||
| Longest Tenure: 2.6 years | |||
| Average Tenure: 2.6 years | |||
| Managers (Year): Vig Dhruv (2024) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 32 |
| % in Top 10 Holdings: | 71.6% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 15.3% |
Portfolio Allocation |
|
| Domestic Stock: | 82.9% |
| Foreign Stock: | 15.3% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 1.8% |
Purchase Information
| Legal Structure: | Open Ended Investment Company |
| Fund Family: | Langar Funds |
| Phone Number: | 800-773-3863 |
| Website: | |
| Inception Date: | January 11, 2024 |
Expenses and Fees
| Expense Ratio (%): | 0.85% (Rating: High) |
| Category Average Expense Ratio (%): | 0.52% |
